Abbott Laboratories (ABT) Enterprise Value (2009 - 2026)

Abbott Laboratories has disclosed Enterprise Value across 18 years of filings, most recently posting $152.1 billion for Q2 2026.

• In Q2 2026, Enterprise Value fell 33.8% year-over-year to $152.1 billion; the TTM figure through Jun 2026 stood at $152.1 billion (down 33.8% YoY), while the FY2025 annual figure was $209.4 billion, up 11.13% from the prior year.
• Enterprise Value came in at $152.1 billion for Q2 2026 at Abbott Laboratories, down from $172.2 billion in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $229.7 billion in Q2 2025 to a low of $152.1 billion in Q2 2026.
• Average Enterprise Value over 5 years is $187.2 billion, with a median of $182.6 billion recorded in 2023.
• Year-over-year, Enterprise Value jumped 32.15% in 2025 and slumped 33.8% in 2026.
• Over 5 years, Enterprise Value stood at $180.9 billion in 2022, then rose by 1.7% to $183.9 billion in 2023, then rose by 2.45% to $188.4 billion in 2024, then increased by 11.13% to $209.4 billion in 2025, then fell by 27.39% to $152.1 billion in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $152.1 billion in Q2 2026, $172.2 billion in Q1 2026, and $209.4 billion in Q4 2025.